Advertisement
Research Article

A Switching Mechanism in Doxorubicin Bioactivation Can Be Exploited to Control Doxorubicin Toxicity

  • Nnenna A. Finn,

    Affiliation: Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia

    X
  • Harry W. Findley,

    Affiliation: The Division of Pediatric Hematology/Oncology, Emory University School of Medicine, Atlanta, Georgia

    X
  • Melissa L. Kemp mail

    melissa.kemp@bme.gatech.edu

    Affiliation: Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia

    X
  • Published: September 15, 2011
  • DOI: 10.1371/journal.pcbi.1002151

Reader Comments (0)

Post a new comment on this article